Skip to main content

Year: 2024

EzFill Announces 2024 Third Quarter Financial Results

— Revenue Increased 13% Year Over Year to $7.0 Million From $6.2 Million — — Gross Profit Increased 74% From The Prior Year Period– –EBITDA Improved 15% from the Prior Year Period– — 1.9 Million Gallons Delivered, Up 26% From The Prior Year Period – –Converted $13.5 Million Debt into Equity— –Recieved $1.4 Million Investment– MIAMI, FL, Nov. 14, 2024 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill” or the “Company”) (NASDAQ: EZFL), a pioneer and emerging leader in the mobile fueling industry, announced today its financial results for the three-month period ended September 30, 2024 (“3Q24” or “third quarter 2024”). 3Q 24 Highlights (in US$, except gallons delivered)  Q3 2024 Q3 2023Financial Highlights    Revenue 6,985,962   6,163,682  Gross Profit 606,825   349,725  Adjusted...

Continue reading

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Achieves Robust Financial Performance with 74% Gross Margin and Strategic Public Offering, Bolstering Resources for Continued Growth and Innovation. Elevai Enfinity™ Clinical Trials Showcase Breakthroughs in Skin Firmness, Tone, and Wrinkle Reduction, Reinforcing Leadership in Aesthetic Innovation. Elevai Biosciences Expands Patent Portfolio with EL-22, a Myostatin-Targeting Treatment for Obesity, Addressing Muscle Preservation in Weight ManagementNEWPORT BEACH, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Elevai Labs Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a pioneering force in medical aesthetics, today reported financial results for the second quarter ended September 30, 2024 and provided a business update. Financial Results for the Three and Six Months Ended June 30, 2024$8 Million Public Offering: Elevai raised...

Continue reading

Kartoon Studios Achieves Second Consecutive Quarter of Sequential Revenue Growth and 57% Year-Over-Year Reduction in Direct Operating Costs for Q3 2024

80% YEAR-OVER-YEAR REDUCTION IN LOSSES; COMPANY POISED FOR CONTINUED REVENUE GROWTH AND REACHING SUSTAINED PROFITABILITY IN 2025 WITH REBOUND IN ANIMATION PRODUCTION PIPELINE AND CONTINUING PROFIT IN CHILDREN’S CHANNEL SYSTEM LARGEST REVENUE UNIT, MAINFRAME, SURGING WITH 145 EPISODES IN PRODUCTION FOR NETFLIX, DISNEY, SONY, SPINMASTER, AND MULTIPLE GLOBAL BROADCASTERS HIGHLY ANTICIPATED A.A. MILNE’S WINNIE-THE-POOH, TO RELEASE SNEAK PEEK ANIMATION TRAILER FEATURING TWO NEW FEMALE CHARACTERS BEVERLY HILLS, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON) today provided a business update for the quarter ended September 30, 2024. Key HighlightsSecond consecutive quarter of sequential revenue growth Significant cost reductions across all operating units resulting in a 57% decrease in direct operating...

Continue reading

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

FDA approval to begin pivotal trial of fully implanted cochlear implant and AMA approval of CPT codes for the Company’s already FDA-approved fully implanted middle ear implant are two of the exciting developments for the growing company WHITE BEAR LAKE, Minn., Nov. 14, 2024 (GLOBE NEWSWIRE) — Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announces its corporate and financial results for the third quarter ended September 30, 2024, as well as other subsequent events. “The progress and accomplishments of late have been extremely important to Envoy Medical as they have set the stage for us to demonstrate the value of fully implanted hearing devices. First, we have received FDA’s approval to start our pivotal trial of the Acclaim® fully...

Continue reading

Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity

— Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors — — Advancement of IkT-001Pro into a Late-Stage Clinical Trial Program in Pulmonary Arterial Hypertension — –201 Trial Results to be reported in 4Q2024 — BOSTON and ATLANTA, Nov. 14, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Cardiopulmonary and Neurodegenerative disease through Abelson Tyrosine Kinase inhibition, today reported financial results for the third quarter ended September 30, 2024 and highlighted recent developments. “The financing we concluded in October was a transformational moment for Inhibikase, and positioned us...

Continue reading

FourPoint Resources, Quantum Capital Group and Kayne Anderson to Acquire Ovintiv Uinta Basin Assets for $2 Billion

DENVER and HOUSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) — FourPoint Resources, LLC (“FourPoint”), together with their partners Quantum Capital Group (“Quantum”) and Kayne Anderson, announced today the signing of a purchase and sale agreement to acquire Ovintiv Inc.’s (NYSE, TSX: OVV) Uinta Basin assets for a purchase price of $2.0 billion in cash. The asset includes 126,000 net acres and production of 29 Mbbls/d. “The opportunity to partner with Quantum and Kayne Anderson, two of the premier private equity firms in energy, will allow our team to immediately begin the work to grow production, cash flow and create value on one of the highest quality, inventory-rich assets in the Lower 48,” said George Solich, Chairman and Chief Executive Officer of FourPoint. Eric Eichler, Chief Operating Officer of FourPoint, said, “The Uinta Basin boasts...

Continue reading

Small Satellite Market to Gain USD 14.54 Billion by 2031 | SkyQuest Technology

Small Satellite Market size was valued at USD 5.46 Billion in 2022 and is poised to grow from USD 6.09 Billion in 2023 to USD 14.54 Billion by 2031, growing at a CAGR of 11.50% during the forecast period (2024-2031). Westford, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Small Satellite Market will attain a value of USD 14.54 Billion by 2031, with a CAGR of 11.50% during the forecast period (2024-2031). The growing need for worldwide communication, real-time data, and remote sensing is expected to fuel the global small satellite market’s expansion. The satellites carry out scientific investigations, help communications and observe the planet. The demand for small satellite solutions is constantly rising as more and more governments and commercial sectors inject funds into space technology. By supporting scientific...

Continue reading

Kaixin Holdings Explores Strategic Alternatives with Potential Acquisition in Crypto Mining Sector

HANGZHOU, China, Nov. 14, 2024 (GLOBE NEWSWIRE) — Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) today announced a major strategic step forward as it explores new growth avenues. In the advanced stages of evaluating strategic alternatives, Kaixin is actively considering the acquisition of a controlling equity interest in a leading cryptocurrency mining company based in the Middle East. This mining company operates with cost-efficient BTC mining machines, optimizing self-mining processes while also offering sophisticated, end-to-end cloud hosting services tailored to meet the growing demand within the crypto mining industry. The facility’s long-term, stable energy supply is a critical asset that bolsters operational resilience and cost efficiency, underscoring Kaixin’s commitment to sustainable and profitable growth. About...

Continue reading

Mawson Infrastructure Group Inc. Reports Q3 2024 Unaudited Financial Results

Q3 2024 Digital Colocation Business Revenue increased 222% Y/YQ3 2024 Energy Management Business Revenue increased 33% Y/YQ3 2024 Total Revenue increased 50% YTD (9 months) in 2024 MIDLAND, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson”, “the Company”), a publicly-traded technology company that offers digital infrastructure platforms for artificial intelligence (AI), high-performance computing (HPC), and digital assets, today announced its unaudited financial and operational results for the third quarter of fiscal year 2024 ended September 30, 2024. Rahul Mewawalla, CEO and President of Mawson, said, “We are pleased to report strong execution and strategic expansion, delivering 222% year-over-year revenue growth in our digital colocation business and 33% year-over-year revenue...

Continue reading

HeartCore Reports Third Quarter 2024 Financial Results

Q3 2024 Revenues Increased 281% to $17.9 Million Q3 2024 Net Income Increased 526% to $10.8 Million NEW YORK and TOKYO, Nov. 14, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 and Recent Operational HighlightsRegained compliance with Nasdaq Listing Requirements Expanded CMS platform offering into a SaaS delivery model Entered into a sales collaboration with Tosho Computer Systems Co., Ltd. Announced transition from annual contracts to multi-year agreements for core software business contracts Partnered with NTT Data Business Brains Corporation to enhance website development service capabilities Achieved top...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.